Access
Access
Ophthalmoplegia Market Size, Historical Analysis, Emerging Technologies 2027
Your avatar
CE
by
celinaredden
Your avatar
CE
by
celinaredden

Market scenario

Ophthalmoplegia, also referred as extra ocular muscle palsy, is a paralysis of the extra ocular muscles that control movements of eyes. In this condition, nerve fibers that coordinate both eyes in horizontal movements looking from side to side- are damaged. A number of devices and treatments are available in the market, which can cure or improve the eyesight of the patient. The Global ophthalmoplegia market is driven by increasing number of people with ophthalmoplegia and increasing geriatric population. According to the World Health Organization in 2010, about 250 million people of over 50 years were suffering from visual impairment. Around 80% people in many of the developing countries have eye sight problems; of which nearly 50% of the people are not able to take treatment due to huge cost of the surgeries. Increasing prevalence of eye sight affecting diseases, for instance, diabetes and rapid developments in technology have fuelled the growth of the market. On the other hand, high cost of the treatment and availability of cheap alternative treatment may slow the growth of the market.

The global ophthalmoplegia market is expected to grow at a CAGR of ~ 7.2 % during the forecast period 2017-2023.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4216

Key Players

Some of key players profiled in the report are Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Valeant Pharmaceuticals International, Inc. (US), Amritt, Inc. (US), Medline Industries, Inc. (US), ALLERGAN (Ireland), and Johnson & Johnson (US).

Segments: The global ophthalmoplegia market has been segmented on the basis of type, treatment and end user.

On the basis of types, the market is segmented into external ophthalmoplegia and internuclear ophthalmoplegia. External ophthalmoplegia is further segmented into superior recti, inferior recti, medial recti, lateral recti, inferior oblique, and superior oblique muscles.

On the basis of treatment, the market is segmented into surgery, drug treatment, and others. The surgery is further segmented into strabismus surgery and others.

On the basis of end users, the market is segmented into hospital & clinics, ambulatory clinics, and others.

Regional analysis:

The Americas dominates the global ophthalmoplegia market owing to well-developed technology and increased patient population with eye sight problem primarily due to increasing prevalence of diabetes. Additionally, high healthcare expenditure and the presence of some of the leading players have fuelled the growth of the market in this region.

Europe is the second largest ophthalmoplegia market, which is followed by Asia Pacific. Increasing government support and availability of funds for research drive the growth of the market. Asia Pacific is the fastest growing ophthalmoplegia market due to increasing geriatric population and rapidly developing medical sector.

On the other hand, the Middle East & Africa holds the least share of the market due to limited availability of medical facilities and poor economic and political conditions in Africa.

Detailed Table of Contents:

1 Report Prologue

2 Market Introduction

2.1 Definition

2.2 Scope Of The Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

3 Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

4 Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs Of The Market

12.2 Key Companies To Watch

12.3 Prediction Of Ophthalmic Industry

13 Appendix

...Continued!

Read More https://www.marketresearchfuture.com/reports/ophthalmoplegia-market-4216

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

0.00€
Cheer up, leave your comment
0
If you liked this post, you may also be interested in...
O
© 2021, Mamby Investments
Information Work with us Terms and Conditions Contact FAQs